6005:TWSECapital Securities Corp. Analysis
Data as of 2026-03-15 - not real-time
CN¥1,413.64
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Kweichow Moutai’s price is currently trading below its short‑term (20‑day) and long‑term (200‑day) moving averages, with RSI hovering in the mid‑40s and a bearish MACD divergence, suggesting limited upside in the near term.
Fundamentally, the company enjoys ultra‑high profitability margins, an exceptionally strong ROE, negligible debt and a solid cash conversion profile, while delivering a dividend yield that is attractive for income‑focused investors. However, the market price is well above the internally estimated discounted cash‑flow fair value and its valuation multiples remain premium, indicating that the stock may be overvalued at present despite its defensive consumer‑staples positioning.
Fundamentally, the company enjoys ultra‑high profitability margins, an exceptionally strong ROE, negligible debt and a solid cash conversion profile, while delivering a dividend yield that is attractive for income‑focused investors. However, the market price is well above the internally estimated discounted cash‑flow fair value and its valuation multiples remain premium, indicating that the stock may be overvalued at present despite its defensive consumer‑staples positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and negative signal line
- Decreasing volume trend reducing short‑term momentum
- Price positioned below key moving averages
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust profitability and cash‑flow generation
- High dividend yield with strong payout capacity
- Defensive consumer‑staples exposure in a stable market
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Iconic brand with entrenched premium pricing power
- Sustained high ROE and low leverage supporting long‑run resilience
- Consistent dividend policy enhancing total return
Key Metrics & Analysis
Financial Health
Revenue Growth0.60%
Profit Margin50.41%
P/E Ratio19.7
ROE36.31%
ROA25.58%
Debt/Equity0.10
P/B Ratio6.9
Op. Cash FlowCN¥86.2B
Free Cash FlowCN¥51.6B
Technical Analysis
TrendNeutral
RSI46.2
SupportCN¥1,383.20
ResistanceCN¥1,568.00
MA 20CN¥1,448.69
MA 50CN¥1,421.81
MA 200CN¥1,446.29
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥618.85
GradeOvervalued
TypeValue
Dividend Yield3.65%
Risk Assessment
Beta0.03
Volatility33.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.